Cognisis® is a patented nutraceutical formulation designed to simultaneously address cognitive decline and malnutrition in elderly populations. Unlike conventional supplements that treat these issues separately, Cognisis® combines targeted bioactive compounds and optimized nutritional delivery to improve brain function, memory retention, and overall health resilience. It offers a dual-action benefit: protecting against neurodegeneration while enhancing nutritional intake, making it a disruptive innovation for healthy aging and elderly care markets.
Cognisis® is a patented formulation that uniquely integrates neuroprotective compounds with nutritional enhancement agents to fight two of the most critical challenges of aging: cognitive decline and malnutrition.
Differentiation: Most existing solutions target memory supplements or nutritional aids in isolation. Cognisis® combines both in a synergistic formulation, maximizing clinical impact.
Clinical Potential: Early trials in elderly care facilities (EHPAD, France) have shown improved patient satisfaction, better compliance, and measurable health improvements.
Market Need: With a rapidly growing global aging population (2B people over 60 by 2050, WHO), demand for integrated solutions for neuro-nutrition is set to surge.
Applications: Elderly care institutions, healthcare providers, dietary supplement brands, and pharmaceutical companies focused on neurodegenerative diseases.
Next Steps: Industrial partners for manufacturing, clinical validation, and commercialization across Europe and international markets.
Intellectual property status
Granted Patent
Patent number : FR3106957B1
Where : France
Current development status
Commercially available technologies
Use of Proceeds
All development work to date has been financed by the founders’ own capital. The product has already been manufactured and successfully tested in partner elderly care facilities. The next stage requires external funding or strategic partnerships to strengthen the sales force and accelerate market penetration across multiple countries.
Joos is a consulting and innovation company founded by seasoned consultants, leveraging decades of international experience in advisory, M&A, and digital transformation. The firm specializes in bridging strategy, technology, and investment, helping clients and partners accelerate growth through innovation and market expansion.
One of the key segments addressed by Joos is healthcare and healthy aging, with a focus on nutraceuticals, digital health, and advanced care solutions. The company has successfully supported projects from early R&D to market deployment, including the Cognisis® patented nutraceutical tested in elderly care facilities in France.
With strong connections to European and Middle Eastern markets, Joos combines advisory excellence, hands-on execution, and investment capabilities to drive cross-border partnerships, scale-up opportunities, and high-impact commercialization.
Create your free account to connect with Yacine Salihy and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Yacine
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
